- Global Pharma News & Resources

Excessive daytime sleepiness Market Key Players, End User, Demand and Consumption by 2030

Excessive daytime sleepiness or Hypersomnia is a sleep disorder of persistent sleep during daytime. Excessive daytime sleepiness is caused by sleep deprivations due to obstructive sleep apnea (OSA), Narcolepsy and other sleep altering/depriving habits, medical or psychiatric conditions.

Narcolepsy is a neurological condition of long term reduced regulation of the sleep-wake cycle and OSA is caused by airway blockages. According to the National Sleep Foundation, 40% of the global population is coping with Excessive Daytime Sleepiness.  Excessive daytime sleepiness is diagnosed with daytime excessive sleepiness, low energy, and frustration. Therapeutic Drugs includes stimulants, anti-depressants, Amphetamine salts and Sodium oxybate.

Devices such as continuous positive airway pressure (CPAP) machine are used for Excessive daytime sleepiness therapies and Nocturnal polysomnography, polysomnography and other devices are used for Excessive daytime sleepiness diagnostics.

For more insights into the market, request a sample of thisreport@ 

Coronavirus and lockdown has propelled the global excessive daytime sleepiness market by the economic crisis, work-from-home stress and disrupted circadian cycle has surged the excessive daytime sleepiness market.

The devices for OSA, including CPAP, BiPAP devices and special ventilators were deliberated with massive production to meet the unprecedented demands of increasing Coronavirus patients. The overall global market of Excessive daytime sleepiness market is growing at lucrative rate.

Excessive daytime sleepiness Market: Drivers and Restraints

The drivers of global excessive daytime sleepiness market include increase of population, awareness, healthcare expenditure diverse drug array and Government reimbursement policies. The advancing R&D and technology of manufacturers and academics rocket the excessive daytime sleepiness market by developing novel therapeutics and unraveling the pathogenesis.

Several targeted drugs and devices for Excessive daytime sleepiness diagnosis and therapies are in pipelines and clinical trials to hit the market. However, the global excessive daytime sleepiness market is constrained by stringent drug regulations of the government, lack of acceptance of OSA masks and wearable because of their discomfort and higher cost.

Although the advancing technologies are propelling the global excessive daytime sleepiness market and open the vast horizon of opportunities of future growth, coupled with the emerging telemedicine technology and mobile health with improved convenience of treatment with the facility of video visiting sleep doctors.

Excessive daytime sleepiness Market: Overview

The global Excessive daytime sleepiness market is expected a growth revamp driven by the increasing Excessive daytime sleepiness disorders, therapy demands and the advancing R&D. By Diseases, OSA dominates the market of excessive daytime sleepiness market with its giant market of devices and drugs.

For Information On The Research Approach Used In The Report, Request TOC@ 

The segment of Narcolepsy is expanding at a faster pace. By treatment, devices for excessive daytime sleepiness market rules the segment with its diverse and massive market of masks, wearable sleep trackers, cushions, Positive Airway Pressure Devices, CPAPs and others.

The segment of Therapeutic drugs is growing at a faster pace of sodium oxybate market. By Distribution channels, Hospitals and sleep centers occupy the largest segment of excessive daytime sleepiness market, propelled by the advanced diagnostics, precision therapies and government reimbursements. The Home Care Settings segment is growing at a faster rate with affordability and comfort.

Excessive daytime sleepiness Market: Regional Outlook

North America dominates the global excessive daytime sleepiness market with rising patients, key players, advanced healthcare and research. Europe holds the second-largest excessive daytime sleepiness market due to its high prevalence of excessive daytime sleepiness and advanced healthcare.

The Asia-Pacific excessive daytime sleepiness market is revamping with the highest growth rate, driven by its rising Excessive daytime sleepiness cases, advancing therapies and technology. South Asian regions including India, where Government and healthcare institution provide aid for awareness and therapies for excessive daytime sleepiness.

Latin America excessive daytime sleepiness market is also growing with the surging cases of OSA and improving healthcare. Middle East & Africa excessive daytime sleepiness market is also elevating due to the surging cases of OSA, narcolepsy and increase in awareness.

Excessive daytime sleepiness Market: Key Players

The key players of global excessive daytime sleepiness market include

  • Teva Pharmaceutical Industries Ltd.
  • GE Healthcare
  • Jazz Pharmaceuticals
  • Compumedics
  • Fisher & Paykel Healthcare
  • BMC Medical Co. Ltd.
  • Avadel Pharmaceuticals plc
  • Cadwell Laboratories Inc. Ltd
  • GlaxoSmithKline plc
  • Braebon Medical Corporation
  • Pfizer
  • Becton Dickinson
  • Theranexus
  • LivaNova PLC and Merck & Co.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies.

The research report provides analysis and information according to market segments such as geographies, application, and industry.

For Information On The Research Approach Used In The Report, Ask Analyst @ 

The report covers exhaust analysis on

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Indication
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.

The report also maps the qualitative impact of various market factors on market segments and geographies.

Excessive daytime sleepiness Market: Segmentation

The global excessive daytime sleepiness market is segmented into diseases, treatment, distribution channels and regions.


  • Obstructive Sleep Apnea (OSA)
  • Narcolepsy


  • Devices (Diagnostics, Therapy)
  • Therapeutic Drugs (Stimulants, Anti-Depressants, Amphetamine salts, Sodium oxybate)

Distribution channels

  • Hospitals & Sleep Laboratories
  • Home Care Settings

For Read More Related Insights:

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.


Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
United Arab Emirates
For Sales Enquiries:
For Media Enquiries:

Editor Details

Last Updated: 09-Jun-2022